JP2019218385A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019218385A5 JP2019218385A5 JP2019156299A JP2019156299A JP2019218385A5 JP 2019218385 A5 JP2019218385 A5 JP 2019218385A5 JP 2019156299 A JP2019156299 A JP 2019156299A JP 2019156299 A JP2019156299 A JP 2019156299A JP 2019218385 A5 JP2019218385 A5 JP 2019218385A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- pharmaceutical composition
- composition according
- calcium
- magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021087768A JP2021130689A (ja) | 2013-12-12 | 2021-05-25 | フマル酸ジメチルを含む医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382504 | 2013-12-12 | ||
| EP13382504.2 | 2013-12-12 | ||
| JP2016538622A JP6581088B2 (ja) | 2013-12-12 | 2014-12-05 | フマル酸ジメチルを含む医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538622A Division JP6581088B2 (ja) | 2013-12-12 | 2014-12-05 | フマル酸ジメチルを含む医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087768A Division JP2021130689A (ja) | 2013-12-12 | 2021-05-25 | フマル酸ジメチルを含む医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019218385A JP2019218385A (ja) | 2019-12-26 |
| JP2019218385A5 true JP2019218385A5 (enExample) | 2020-07-16 |
| JP6945603B2 JP6945603B2 (ja) | 2021-10-06 |
Family
ID=49917530
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538622A Active JP6581088B2 (ja) | 2013-12-12 | 2014-12-05 | フマル酸ジメチルを含む医薬組成物 |
| JP2019156299A Active JP6945603B2 (ja) | 2013-12-12 | 2019-08-29 | フマル酸ジメチルを含む医薬組成物 |
| JP2021087768A Pending JP2021130689A (ja) | 2013-12-12 | 2021-05-25 | フマル酸ジメチルを含む医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538622A Active JP6581088B2 (ja) | 2013-12-12 | 2014-12-05 | フマル酸ジメチルを含む医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087768A Pending JP2021130689A (ja) | 2013-12-12 | 2021-05-25 | フマル酸ジメチルを含む医薬組成物 |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US20160310457A1 (enExample) |
| EP (2) | EP3079666B1 (enExample) |
| JP (3) | JP6581088B2 (enExample) |
| KR (2) | KR102335289B1 (enExample) |
| CN (2) | CN105813634A (enExample) |
| AR (1) | AR098746A1 (enExample) |
| AU (2) | AU2014363792B2 (enExample) |
| BR (1) | BR112016012179B1 (enExample) |
| CA (2) | CA2932054C (enExample) |
| CL (1) | CL2016001415A1 (enExample) |
| CY (1) | CY1124336T1 (enExample) |
| DK (1) | DK3079666T3 (enExample) |
| EA (1) | EA201600457A1 (enExample) |
| ES (1) | ES2860551T3 (enExample) |
| HR (1) | HRP20210468T1 (enExample) |
| HU (1) | HUE054408T2 (enExample) |
| IL (2) | IL287109B (enExample) |
| LT (1) | LT3079666T (enExample) |
| MX (2) | MX375144B (enExample) |
| MY (1) | MY179355A (enExample) |
| NZ (2) | NZ720287A (enExample) |
| PH (2) | PH12016501043B1 (enExample) |
| PL (1) | PL3079666T3 (enExample) |
| PT (1) | PT3079666T (enExample) |
| RS (1) | RS61658B1 (enExample) |
| SG (3) | SG10201802815UA (enExample) |
| SI (1) | SI3079666T1 (enExample) |
| SM (1) | SMT202100205T1 (enExample) |
| TW (2) | TWI704915B (enExample) |
| UA (2) | UA123880C2 (enExample) |
| WO (1) | WO2015086467A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2713157T3 (es) | 2014-02-28 | 2019-05-20 | Banner Life Sciences Llc | Cápsulas blandas entéricas de liberación controlada de ésteres de fumarato |
| US9326947B1 (en) | 2014-02-28 | 2016-05-03 | Banner Life Sciences Llc | Controlled release fumarate esters |
| US10098863B2 (en) | 2014-02-28 | 2018-10-16 | Banner Life Sciences Llc | Fumarate esters |
| US9636318B2 (en) | 2015-08-31 | 2017-05-02 | Banner Life Sciences Llc | Fumarate ester dosage forms |
| US10085961B2 (en) | 2015-06-01 | 2018-10-02 | Sun Pharmaceutical Industries Limited | Pharmaceutical compositions of dimethyl fumarate |
| WO2016205754A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Compositions and methods for modified nutrient delivery |
| WO2016205701A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Enteral fast access tract platform system |
| WO2017040272A1 (en) * | 2015-08-31 | 2017-03-09 | Banner Life Sciences Llc | Fumarate ester dosage forms |
| WO2017114593A1 (en) * | 2015-12-31 | 2017-07-06 | Zaklady Farmaceutyczne Polpharma S.A. | Process for preparation of an enteric coated granulate comprising dimethyl fumarate |
| WO2017129370A1 (en) * | 2016-01-28 | 2017-08-03 | Zaklady Farmaceutyczne Polpharma S.A. | Process for preparation of a granulate comprising dimethyl fumarate |
| US20190029987A1 (en) * | 2016-02-12 | 2019-01-31 | Universitat Zurich | Dimethyl fumarate (dmf) for prevention or treatment of gout, acne, diabetes, vitiligo and/or pyoderma gangrenosum |
| WO2017145036A1 (en) * | 2016-02-25 | 2017-08-31 | Aurobindo Pharma Ltd | Pharmaceutical compositions comprising dimethyl fumarate |
| AU2018287442A1 (en) * | 2017-06-23 | 2019-11-07 | Almirall, S.A. | Pharmaceutical compositions comprising dimethyl fumarate |
| JP7000148B2 (ja) * | 2017-12-27 | 2022-01-19 | 日本化薬株式会社 | ダサチニブを有効成分とする医薬組成物 |
| WO2020053219A1 (en) | 2018-09-13 | 2020-03-19 | Almirall, S.A. | Treatment of psoriasis |
| WO2020053218A1 (en) | 2018-09-13 | 2020-03-19 | Almirall, S.A. | Treatment of psoriasis |
| PH12021552668A1 (en) * | 2019-05-31 | 2022-09-19 | Curacle Co Ltd | Enteric tablet containing dimethyl fumarate |
| CA3158394A1 (en) * | 2019-11-07 | 2021-05-14 | Asahi Kasei Kabushiki Kaisha | Cellulose composition and tablet |
| WO2021142062A1 (en) | 2020-01-10 | 2021-07-15 | Banner Life Sciences Llc | Fumarate ester dosage forms with enhanced gastrointestinal tolerability |
| TW202207940A (zh) * | 2020-04-14 | 2022-03-01 | 美商健生生物科技公司 | 包含胺基嘧啶衍生物或其醫藥上可接受之鹽、水合物、或溶劑化物之用於經口投予之醫藥組成物 |
| WO2022203432A1 (ko) * | 2021-03-25 | 2022-09-29 | 주식회사 큐라클 | 특정 약동학적 매개변수를 나타내는 디메틸푸마레이트를 유효성분으로 함유한 약학적 조성물 |
| WO2022212893A1 (en) * | 2021-04-02 | 2022-10-06 | Biogen Ma Inc. | Combination treatment methods of multiple sclerosis |
| WO2024232931A1 (en) * | 2023-05-11 | 2024-11-14 | Yon Doo Ough | Apparatus and method for contact free delivery and administration of magnesium as a drug |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4959389A (en) | 1987-10-19 | 1990-09-25 | Speiser Peter P | Pharmaceutical preparation for the treatment of psoriatic arthritis |
| DE19848260C2 (de) | 1998-10-20 | 2002-01-17 | Fumapharm Ag Muri | Fumarsäure-Mikrotabletten |
| DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| DE10101307A1 (de) * | 2001-01-12 | 2002-08-01 | Fumapharm Ag Muri | Fumarsäurederivate als NF-kappaB-Inhibitor |
| CN101056624A (zh) * | 2004-10-08 | 2007-10-17 | Adi技术制药股份公司 | 包含富马酸酯的控释药物组合物 |
| PL2316430T3 (pl) * | 2004-10-08 | 2012-11-30 | Forward Pharma As | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu, zawierające ester kwasu fumarowego |
| JP5149160B2 (ja) * | 2005-04-28 | 2013-02-20 | ワイス・エルエルシー | ミクロ化タナプロゲットおよびこれを含む組成物 |
| EP1940382A2 (en) * | 2005-10-07 | 2008-07-09 | Aditech Pharma AB | Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| WO2007042034A1 (en) * | 2005-10-07 | 2007-04-19 | Aditech Pharma Ab | Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| CN101304732A (zh) * | 2005-10-07 | 2008-11-12 | Adi技术制药股份公司 | 包含富马酸酯的控释药物组合物 |
| WO2009118764A1 (en) * | 2008-03-28 | 2009-10-01 | Panacea Biotec Limited | Pharmaceutical composition comprising diclofenac and paracetamol |
| WO2010079222A1 (en) | 2009-01-09 | 2010-07-15 | Forward Pharma A/S | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
| EP2379062A1 (en) | 2009-01-09 | 2011-10-26 | Forward Pharma A/S | Pharmaceutical composition comprising one or more fumaric acid esters |
| EP3318249A1 (en) * | 2009-04-29 | 2018-05-09 | Biogen MA Inc. | Dimethyl fumarate dosage regimens for the treatment of multiple sclerosis |
| AR086647A1 (es) * | 2011-06-03 | 2014-01-15 | Hoffmann La Roche | Metodos para tratar el mesotelioma con un compuesto inhibidor de la pi3k |
| RU2014125430A (ru) | 2011-11-24 | 2015-12-27 | Синтон Бв | Контролируемое высвобождение частиц, содержащих диметилфумарат |
| JP6189333B2 (ja) * | 2012-02-07 | 2017-08-30 | バイオジェン エムエー インコーポレーテッド | フマル酸ジメチルを含有する医薬組成物 |
-
2014
- 2014-12-05 NZ NZ720287A patent/NZ720287A/en unknown
- 2014-12-05 IL IL287109A patent/IL287109B/en unknown
- 2014-12-05 HR HRP20210468TT patent/HRP20210468T1/hr unknown
- 2014-12-05 SG SG10201802815UA patent/SG10201802815UA/en unknown
- 2014-12-05 US US15/103,465 patent/US20160310457A1/en not_active Abandoned
- 2014-12-05 EP EP14809821.3A patent/EP3079666B1/en active Active
- 2014-12-05 NZ NZ759411A patent/NZ759411A/en unknown
- 2014-12-05 KR KR1020167015498A patent/KR102335289B1/ko active Active
- 2014-12-05 CA CA2932054A patent/CA2932054C/en active Active
- 2014-12-05 BR BR112016012179-1A patent/BR112016012179B1/pt active IP Right Grant
- 2014-12-05 SM SM20210205T patent/SMT202100205T1/it unknown
- 2014-12-05 UA UAA201906965A patent/UA123880C2/uk unknown
- 2014-12-05 AU AU2014363792A patent/AU2014363792B2/en active Active
- 2014-12-05 RS RS20210404A patent/RS61658B1/sr unknown
- 2014-12-05 EP EP19217154.4A patent/EP3656379A1/en active Pending
- 2014-12-05 SG SG10201913080VA patent/SG10201913080VA/en unknown
- 2014-12-05 PT PT148098213T patent/PT3079666T/pt unknown
- 2014-12-05 MX MX2016007105A patent/MX375144B/es active IP Right Grant
- 2014-12-05 HU HUE14809821A patent/HUE054408T2/hu unknown
- 2014-12-05 EA EA201600457A patent/EA201600457A1/ru unknown
- 2014-12-05 PL PL14809821T patent/PL3079666T3/pl unknown
- 2014-12-05 UA UAA201607363A patent/UA120428C2/uk unknown
- 2014-12-05 DK DK14809821.3T patent/DK3079666T3/da active
- 2014-12-05 JP JP2016538622A patent/JP6581088B2/ja active Active
- 2014-12-05 SG SG10201913076PA patent/SG10201913076PA/en unknown
- 2014-12-05 ES ES14809821T patent/ES2860551T3/es active Active
- 2014-12-05 CN CN201480066692.8A patent/CN105813634A/zh active Pending
- 2014-12-05 WO PCT/EP2014/076767 patent/WO2015086467A1/en not_active Ceased
- 2014-12-05 CA CA3135273A patent/CA3135273A1/en not_active Abandoned
- 2014-12-05 CN CN202111543717.7A patent/CN114159421B/zh active Active
- 2014-12-05 KR KR1020217038861A patent/KR102353201B1/ko active Active
- 2014-12-05 SI SI201431799T patent/SI3079666T1/sl unknown
- 2014-12-05 MY MYPI2016702094A patent/MY179355A/en unknown
- 2014-12-05 LT LTEP14809821.3T patent/LT3079666T/lt unknown
- 2014-12-10 TW TW108144916A patent/TWI704915B/zh active
- 2014-12-10 TW TW103143092A patent/TWI687218B/zh active
- 2014-12-12 AR ARP140104646A patent/AR098746A1/es unknown
-
2016
- 2016-05-17 IL IL245685A patent/IL245685B/en unknown
- 2016-06-01 MX MX2020009745A patent/MX2020009745A/es unknown
- 2016-06-02 PH PH12016501043A patent/PH12016501043B1/en unknown
- 2016-06-09 CL CL2016001415A patent/CL2016001415A1/es unknown
-
2019
- 2019-08-29 JP JP2019156299A patent/JP6945603B2/ja active Active
- 2019-11-19 AU AU2019268075A patent/AU2019268075B2/en active Active
- 2019-11-21 PH PH12019502610A patent/PH12019502610A1/en unknown
-
2021
- 2021-04-27 CY CY20211100359T patent/CY1124336T1/el unknown
- 2021-05-11 US US17/316,861 patent/US20210330628A1/en not_active Abandoned
- 2021-05-25 JP JP2021087768A patent/JP2021130689A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019218385A5 (enExample) | ||
| JP2016540003A5 (enExample) | ||
| HRP20210468T1 (hr) | Farmaceutski pripravci koji sadrže dimetil fumarat | |
| HRP20240355T1 (hr) | 8-cijano-5-piperidino-kinolini kao tlr7/8 antagonisti i njihova upotreba u liječenju imunoloških poremećaja | |
| HRP20170904T1 (hr) | Formulacije tableta (4'-trifluormetilfenil)-amida (z)-2-cijano-3-hidroksi-but-2-enske kiseline s poboljšanom stabilnošću | |
| US7449598B2 (en) | Methods for the preparation, formulation and use of lithium valproate | |
| CN110944638A (zh) | 尼拉帕尼组合物 | |
| KR102759845B1 (ko) | 2-｛4-[n-(5,6-디페닐피라진-2-일)-n-이소프로필아미노]부틸옥시｝-n-(메틸술포닐)아세트아미드를 함유하는 의약 조성물 | |
| WO2015115582A1 (ja) | アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤 | |
| ME01629B (me) | Upotreba 3,11 b-cis-dihidrotetrabenazina za tretman simptoma huntington-ove bolesti | |
| JPWO2021111124A5 (enExample) | ||
| JP2008528702A5 (enExample) | ||
| JP2015166342A5 (enExample) | ||
| Xu et al. | Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2, 3, 4, 5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in rats | |
| JP2020502137A5 (enExample) | ||
| JP2020524685A5 (enExample) | ||
| Beretta et al. | Postural adjustments of active youths in perturbation and dual-task conditions | |
| KR102254307B1 (ko) | 보관 안정성이 향상된 에페리손 약제학적 조성물 | |
| EP2599481A1 (en) | 4-phenylbutyric acid for the treatment or prevention of various diseases | |
| JP2022552877A (ja) | 発達障害の予防、軽減又は治療のためのイミダゾピリミジン又はイミダゾトリアジン化合物の使用 | |
| WO2019190432A2 (en) | Tolperisone and non-selective cox inhibitor combinations | |
| HK40024686A (en) | Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith | |
| JPWO2021099531A5 (enExample) | ||
| HK1224212B (en) | Pharmaceutical compositions comprising dimethyl fumarate | |
| JP2005187459A (ja) | スルホキシド誘導体の塩酸塩の結晶 |